| Susan Passalaqua, MD | |
|
2946 E Banner Gateway Dr., Gilbert, AZ 85234 | |
| (480) 256-6444 | |
| (480) 256-4683 |
| Full Name | Susan Passalaqua |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 2946 E Banner Gateway Dr., Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891784880 | NPI | - | NPPES |
| 843880 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 32391 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Mckennan Hospital & University Health Center | Sioux falls, SD | Hospital |
| Avera Heart Hospital Of South Dakota | Sioux falls, SD | Hospital |
| Brookings Health System | Brookings, SD | Hospital |
| Avera Marshall Regional Medical Ctr | Marshall, MN | Hospital |
| Regional Health Services Of Howard County | Cresco, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
| Madison Community Hospital | 3779579743 | 39 |
| Avera Marshall | 5799695227 | 75 |
| Urology Specialists Chartered | 9234031329 | 41 |
| Avera Queen Of Peace | 9335050806 | 84 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Avera Queen Of Peace |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Urology Specialists Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881647246 PECOS PAC ID: 9234031329 Enrollment ID: O20040121000003 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Madison Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588644058 PECOS PAC ID: 3779579743 Enrollment ID: O20040423000982 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Madison Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1588644058 PECOS PAC ID: 3779579743 Enrollment ID: O20101012001097 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Entity Name | Avera Marshall |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962641936 PECOS PAC ID: 5799695227 Enrollment ID: O20191211001152 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Passalaqua, MD 2940 E Banner Gateway Dr. Ste 450, Gilbert, AZ 85234 Ph: (480) 425-5063 | Susan Passalaqua, MD 2946 E Banner Gateway Dr., Gilbert, AZ 85234 Ph: (480) 256-6444 |
News Archive
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
MetLife, providing dental plan administration for over 20 million people, today announced its new Dental Health Maintenance Organization (DHMO) MET Series of Copay plans.
Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).
A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
› Verified 4 days ago
Dr. Georg Hernandez, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4001 E Baseline Rd Ste 105, Gilbert, AZ 85234 Phone: 480-632-5378 Fax: 480-632-1821 | |
Yerko O Borghero, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-3676 Fax: 480-256-3608 | |
Dr. Joel R Meyer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Banner Md Anderson Cancer Center, 2940 E. Banner Gateway Drive Suite 350, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Sarah E Nicholas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Banner Md Anderson Cancer Center, 2946 E. Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Dr. Matthew D Callister, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 2940 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 | |
Dr. Philippe Lanauze, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Gary Walker, M.D., M.P.H., M.S. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-4500 |